171
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Toxicokinetic of flumethrin in rabbitsFootnote

&
Pages 92-97 | Received 19 Oct 2013, Accepted 30 Mar 2014, Published online: 28 Apr 2014
 

Abstract

In this study, the toxicokinetic of flumethrin after single oral and intravenous applications were studied. For this aim, 14 male New Zealand rabbits were used. The animals were divided into two groups of seven each. While 10 mg/kg.bw of flumethrin was intravenously injected into the first group, the same dose was administered orally with the second group. Serial blood samples were also collected at certain periods. Flumethrin concentrations were measured using a gas chromatography with a micro electron capture detector. The serum flumethrin concentration-time curve was determined to fit a two-compartment open model. Among the parameters calculated following intravenous application of flumethrin, the half-life at β phase (t1/2β), mean residence time (MRT) and area under the concentration time curve in 0–∞ (AUC0→∞) values were respectively found to be 34.0 ± 4.2 h, 48.0 ± 5.8 h and 36.1 ± 5.3. On the other hand, the maximal concentration in serum (Cmax), time needed to reach Cmax (tmax), t1/2β, MRT and AUC0→∞ values of flumethrin after oral administration were determined to be 0.54 ± 0.09 μg/ml, 5.42 ± 0.97 h, 43.3 ± 8.6 h, 59.7 ± 10.5 h and 22.0 ± 2.0 mg.h/L, respectively. The bioavailability of flumethrin was found to be 60.9%. In conclusion, these results were considered to be important in terms of the toxication risk of flumethrin and its safe use.

Acknowledgements

This research (project code: TSY-10-2975) was supported by the Research Fund of Erciyes University.

Declaration of interest

The authors declare that there are no conflicts of interest.

Notes

This study is the MSc thesis of Züleyha Başçi.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.